Professor Gökhan Hotamışlıgil received the 2018 EASD–Novo Nordisk Foundation Diabetes Prize for Excellence for his outstanding research efforts that have led to groundbreaking new knowledge about the relationship between obesity and diabetes and potential paths for treatment.
The Prize is awarded to an international researcher for outstanding scientific contributions that have increased our knowledge of diabetes. The EASD–Novo Nordisk Foundation Diabetes Prize for Excellence is being awarded to recognize outstanding research or technology contributions to the understanding of diabetes, its disease mechanisms or its complications. The Prize is awarded annually to an internationally recognized researcher whose research may focus on prevention, treatment and/or basic research in physiological biochemistry. The research may also be clinically oriented. In addition, the Prize may be awarded for the “discovery of the decade” within diabetes research. Established in 2015, the Prize is awarded in collaboration between the European Association for the Study of Diabetes (EASD) and the Novo Nordisk Foundation. It is accompanied by DKK 6 million – of which DKK 1 million is a personal award and the remaining DKK 5 million is for research purposes. A special prize committee appointed by the EASD decides the winner of the Prize, and the Novo Nordisk Foundation donates the funds accompanying the Prize. Employees of universities, hospitals or other non-profit institutions are considered for the Prize. Candidates must be highly renowned and may be of any nationality. The Prize is conferred at the EASD Annual Meeting at which the Prize recipient is invited to give a lecture.